Search Results 551-560 of 13327 for monoclonal antibody

  1. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  2. Talquetamab-tgvs (subcutaneous route) - Side effects & uses - Mayo Clinic

    These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

  3. Dinutuximab (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine is a GD2-binding monoclonal antibody. This medicine is to be given only by or under the direct supervision of your doctor. This product is ...

  4. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer ...

  5. Ide-cel, a BCMA-directed CAR-T cell therapy, shows favorable risk-benefit profile and response - Mayo Clinic

    ... monoclonal antibodies. The dose escalation phase of the study (50, 140, 450 and 800 x 106 total fixed doses of CAR -T cells) involved 21 patients; in the ...

  6. Teclistamab-cqyv (subcutaneous route) - Side effects & uses - Mayo Clinic

    These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

  7. Penpulimab-kcqx (intravenous route) - Side effects & uses - Mayo Clinic

    Penpulimab-kcqx is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...

  8. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody treatment can help high-risk patients with COVID-19 featured image. Featured News. Monoclonal antibody treatment can help high-risk ...

  9. Clinical trials - Oncology (Medical)

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  10. Medical Research & Education - Mayo Clinic News Network

    Latest stories · Monoclonal antibodies help COVID-19 patients avoid hospitalization featured image · Strong immune response underlies acute kidney injury related ...